Foamix Disappointing IPO Drops Share Price to $6

Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price to only $6 from the previously expected $10 to $12 range. The More...

Israeli Acne Treating Startup Wants $75 Million in IPO

Israeli startup Foamix Ltd, which makes foams used for drug delivery and has recently developed a new treatment for acne, has announced plans for an IPO in which it expects to raise more than $75 million. More...